Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Therapeuticsmd Inc (TXMD)

Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Therapeuticsmd Inc 951 Yamato Road Suite 220 BOCA RATON FL 33431 USA

www.therapeuticsmd.com P: 561-961-1900

Description:

TherapeuticsMD, Inc. is a specialty pharmaceutical company focused on creating branded prescription, generic prescription and over-the-counter products targeted exclusively for women. It is developing three advanced hormone replacement products designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies. TherapeuticsMD, Inc. is based in Boca Raton, Florida.

Key Statistics

Overview:

Market Capitalization, $K 22,141
Enterprise Value, $K 17,811
Shares Outstanding, K 11,532
Annual Sales, $ 1,300 K
Annual Net Income, $ -10,280 K
Last Quarter Sales, $ 500 K
Last Quarter Net Income, $ -880 K
EBIT, $ -7,590 K
EBITDA, $ -6,670 K
60-Month Beta 1.03
% of Insider Shareholders 1.20%
% of Institutional Shareholders 30.74%
Float, K 11,394
% Float 98.80%
Short Volume Ratio 0.54

Growth:

1-Year Return -48.11%
3-Year Return -96.83%
5-Year Return -99.12%
5-Year Revenue Growth -91.93%
5-Year Earnings Growth 97.49%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.13 on 11/14/23
Latest Earnings Date 05/20/24
Earnings Per Share ttm -0.61
EPS Growth vs. Prev Qtr 45.83%
EPS Growth vs. Prev Year 95.85%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-50 on 05/09/22

TXMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -25.54%
Return-on-Assets % -14.87%
Profit Margin % -790.77%
Debt/Equity 0.00
Price/Sales 16.65
Price/Cash Flow N/A
Price/Book 0.68
Book Value/Share 2.77
Interest Coverage -0.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar